Novo Nordisk A/S (NOVO-B.CO) Financials

NOVO-B.CO Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 559.2 billion 356.2 billion
Dec. 31, 2025 542.9 billion 348.9 billion
Sept. 30, 2025 512.3 billion 342.4 billion
June 30, 2025 482.2 billion 314.1 billion

NOVO-B.CO Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 12.0 billion ?
Dec. 31, 2025 -36.2 billion ?
Sept. 30, 2025 30.7 billion ?
June 30, 2025 24.5 billion ?

NOVO-B.CO Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 48.6 billion
Dec. 31, 2025 26.9 billion
Sept. 30, 2025 20.0 billion
June 30, 2025 26.5 billion

NOVO-B.CO Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 21.6 billion 119.2 billion -
Dec. 31, 2025 27.0 billion 111.7 billion 7.2 billion
Sept. 30, 2025 32.6 billion 89.2 billion -
June 30, 2025 18.9 billion 87.3 billion -

NOVO-B.CO Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 4.4 billion
Dec. 31, 2025 4.4 billion
Sept. 30, 2025 4.4 billion
June 30, 2025 4.4 billion

NOVO-B.CO Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 12.0 billion 10.3 billion 13.2 billion 12.1 billion
Dec. 31, 2025 43.8 billion 14.6 billion 17.4 billion 15.9 billion
Sept. 30, 2025 15.4 billion 15.4 billion 17.9 billion 16.0 billion
June 30, 2025 16.3 billion 11.7 billion 18.8 billion 17.5 billion

NOVO-B.CO Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 96.8 billion 13.6 billion
Dec. 31, 2025 79.1 billion 15.1 billion
Sept. 30, 2025 75.0 billion 17.9 billion
June 30, 2025 76.9 billion 12.8 billion

NOVO-B.CO

Price: DKK287.25

52 week price:
216.77
605.50

Dividend Yield: 3.90%

5-year range yield:
0.75%
5.87%

Forward Dividend Yield: 5.54%

Payout Ratio: 34.79%

Payout Ratio Range:
0.01%
449.50%

Dividend Per Share: 15.90 DKK

Earnings Per Share: 27.42 DKK

P/E Ratio: 11.01

Exchange: CPH

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: Denmark

Volume: 2.2 million

Market Capitalization: 1.3 trillion

Average Dividend Frequency: 2

Years Paying Dividends: 27

DGR3: 8.84%

DGR5: 9.95%

DGR10: 13.03%

DGR20: 11.63%

Links: